Please login to the form below

Not currently logged in
Email:
Password:

True North Therapeutics

This page shows the latest True North Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Third time lucky? Sanofi cuts an $11.6bn deal to buy Bioverativ

Third time lucky? Sanofi cuts an $11.6bn deal to buy Bioverativ

north of $1bn in 2017 - as well as a pipeline of blood disorder products. ... Since splitting off from Biogen, Bioverativ has added to its pipeline by buying True North Therapeutics for $825m last May, a deal which brought in lead pipeline candidate

Latest news

  • Biogen spin-out makes first acquisition Biogen spin-out makes first acquisition

    Bioverativ attains rare disease group True North. Just three months after splitting from Biogen, Bioverativ has inked its first major deal adding a new clinical candidate to its pipeline via a ... $825m deal to buy True North Therapeutics.

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • BioMarin’s chief commercial officer joins True North’s board BioMarin’s chief commercial officer joins True North’s board

    California, US-based biotech True North Therapeutics has appointed Jeff Ajer to its board of directors as an independent director. ... Nancy Stagliano, chief executive officer of True North Therapeutics, said: “We are delighted that Jeff has joined our

  • Amgen finance VP joins True North Therapeutics Amgen finance VP joins True North Therapeutics

    Pamela Wapnick appointed as chief financial officer. California-based True North Therapeutics has appointed Pamela Wapnick as its new chief financial officer. ... She brings over 25 years of international business and finance experience to True North,

More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....

Infographics